News

D.O.G.E. job cuts, tariffs, a restrictive Fed and new immigration policies could weigh on markets for the next six to nine months, said Lekker Capital's Quinn Thompson.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) jumped 94.9% in the afternoon session after the company announced that its Phase 3 trial (ROSELLA) met its goal of improving progression-free survival and overall survival in treating resistant ovarian cancer with a new therapy (a combination of Relacorilant and Nab-paclitaxel).

While yields across major lending platforms have compressed significantly, innovation at the market's edges demonstrates DeFi's continued maturation and growth, says Ryan Rodenbaugh, CEO of Wallfacer Labs, the team behind vaults.fyi.

Shares of conservative news outlet Newsmax skyrocketed in the company’s first day of trading on the New York Stock Exchange Monday after a $75 million initial public offering.

Shares of Canada Goose Holdings set a new record low Monday after analysts from Barclays downgraded the apparel maker's stock.

Lululemon’s CEO says the company is tackling its “newness” problem. Unfortunately, it has other problems, too.

The agency is determined to treat crypto derivatives the same way it treats everything else.